Growing Heart Valve Implants for Children

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Pediatric Cardiology

Background:

• Current heart valve implants for pediatric patients with congenital valvular disease do not accommodate somatic growth.
• This limitation prevents long-term clinical success in children requiring valve replacement.
• There is a critical need for pediatric heart valve solutions that can grow with the patient.

Purpose of the Study:

• To review recent advancements in tissue-engineered heart valves (TEHVs) and partial heart transplantation.
• To evaluate these approaches as potential growing heart valve implants for pediatric patients.
• To discuss the barriers hindering clinical translation of these innovative therapies.

Main Methods:

• Review of in vitro and in situ designs for tissue-engineered heart valves.
• Analysis of large animal studies and clinical translational research.
• Identification of challenges in the clinical application of growing heart valve technologies.

Main Results:

• Tissue engineering and partial transplantation show promise as growing heart valve alternatives.
• Significant progress has been made in designing and testing TEHVs.
• Translational research in large animals provides a basis for clinical application.

Conclusions:

• Tissue-engineered heart valves and partial heart transplantation represent promising avenues for pediatric growing heart valve solutions.
• Overcoming barriers in design, manufacturing, and clinical integration is crucial for successful translation.
• These regenerative approaches offer hope for improved long-term outcomes in children with congenital valvular disease.